Sherwyn L Schwartz MD

Endocrinology•San Antonio, TX

Diabetes, Lipid Metabolism

Endocrinologist

Join to View Full Profile

8042 wurzbach suite 420San Antonio, TX 78229
Phone+1 210-949-0807

Education & Training

Rush University Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1976 - 1977
Michael Reese Hospital and Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1975 - 1976
Michael Reese Hospital and Medical CenterResidency, Internal Medicine, 1972 - 1975
University of Illinois College of MedicineClass of 1972

Certifications & Licensure

CA State Medical License 1977 - Present
IL State Medical License 1973 - Present
TX State Medical License 1977 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

Super Doctor SuperDoctors.com
Top MD Consumers Checkbook

Clinical Trials

Safety and Efficacy of PEG-Encapsulated Islet Allografts Implanted in Type I Diabetic Recipients Start of enrollment: 2005 Nov 01
Terminated
Phase 1, Phase 2
The Effect of Betahistine on Body Weight in Obese Subjects Start of enrollment: 2007 Jan 01
Completed
Phase 2
Safety and Tolerability Study of MBX-2044 in Patients With Type 2 Diabetes Start of enrollment: 2006 Oct 01
Completed
Phase 2
A Prospective, Randomized, Parallel Crossover Study Demonstrating Subject Wearability and Usability of the I-Port Injection Port Start of enrollment: 2006 Oct 01
Completed
Not Applicable
A Phase 2b Study of DIO-902 or DIO-902 Placebo in Addition to Metformin and Atorvastatin or Atorvastatin Placebo for Type 2 Diabetes Start of enrollment: 2007 Jul 01
Terminated
Phase 2
A Study to Evaluate the Effect of Nasal Insulin on Postprandial Glycemic Control in Type 2 Diabetic Patients Start of enrollment: 2008 Mar 01
Completed
Phase 2
Pharmacokinetic Study of Oral Testosterone (T) Ester Formulations in Hypogonadal Men Start of enrollment: 2008 Jun 01
Completed
Phase 2
Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data Start of enrollment: 2013 Nov 26
Completed
Not Applicable
Appearance of Plasma Amino Acids Following Consumption of an Oral Nutrition Supplement Start of enrollment: 2016 Feb 01
Completed
Not Applicable
Join now to see all

Publications & Presentations

PubMed

Non-alcoholic Steatohepatitis: From Pathophysiology to Clinical Practice
Sherwyn Schwartz, Jean Lucas, Mark H DeLegge, Iqvia, Raleigh, Nc, Usa
Touchreviews in Endocrinology. 2021-01-01
1 citations
Plasma glucose and insulin response to two oral nutrition supplements in adults with type 2 diabetes mellitus.
Maureen B. Huhmann, Kristen N Smith, Sherwyn L Schwartz, Stacie K Haller, Sarah R. Irvin
BMJ Open Diabetes Research & Care. 2016-08-01
30 citations
A pooled analysis evaluating the efficacy and tolerability of tapentadol extended release for chronic, painful diabetic peripheral neuropathy.
Sherwyn Schwartz, Mila Etropolski, Douglas Y. Shapiro, C. Rauschkolb, Aaron I. Vinik
Clinical Drug Investigation. 2015-02-01

Press Mentions

How a New COVID Vaccine Type Could Eliminate the Need for BoostersNovember 22nd, 2022
More San Antonio Hispanics Need to Participate in Coronavirus Vaccine Trials, Officials UrgeDecember 6th, 2020
Effect of Alendronate and MK-677 (A Growth Hormone Secretagogue), Individually and in Combination, on Markers of Bone Turnover and Bone Mineral Density in Postmenopausal Osteoporotic WomenJuly 22nd, 2020
Join now to see all

Professional Memberships

American Association of Clinical Endocrinologists - AACE
Member